Literature DB >> 23393697

Neurocognitive dysfunction in old diabetes: management and treatment.

Hiroyuki Umegaki1.   

Abstract

Type 2 diabetes mellitus (T2DM) is a risk factor for cognitive decline. However, the etiology of dementia and cognitive impairment in people with T2DM is probably multifactorial, and the precise underlying mechanism remains unclear. Good metabolic control in elderly subjects with T2DM may contribute to prevention of the development and/or progression of cognitive decline in elderly diabetic subjects, but hypoglycemia must be avoided. Appropriate well-balanced glycaemic control should be provided to diabetic subjects with cognitive impairment. Demented diabetic patients tend to lose self-caring ability, and behavioural and psychological symptoms of dementia (BPSD) and depressive mood; the symptoms often associated with dementia, make the management of diabetes complicated and difficult. Considering the progressive aging world-wide, more research to investigate the association between T2DM and dementia process, as well as the best way to manage this population, will be important.

Entities:  

Mesh:

Year:  2012        PMID: 23393697     DOI: 10.1007/978-1-4614-5441-0_33

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  A J Carman; P A Dacks; R F Lane; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

Review 2.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 3.  Contribution of hyperglycemia-induced changes in microglia to Alzheimer's disease pathology.

Authors:  Maricarmen Hernández-Rodríguez; Cecilia Flores Clemente; Martha Edith Macías-Pérez; Rolando Alberto Rodríguez-Fonseca; M Inés Nicolás Vázquez; Joel Martínez; Rene Miranda Ruvalcaba; Martín Martínez Rosas; Elvia Mera Jiménez
Journal:  Pharmacol Rep       Date:  2022-08-31       Impact factor: 3.919

4.  Neurocognitive dysfunction among type 2 diabetes patients attending primary health care in Jeddah, Saudi Arabia.

Authors:  Alshaymaa A Alshaikh; Hind S Alatawi; Abdullah M Alzahrani
Journal:  J Family Med Prim Care       Date:  2021-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.